114 related articles for article (PubMed ID: 12050274)
1. Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.
Sowell MO; Mukhopadhyay N; Cavazzoni P; Shankar S; Steinberg HO; Breier A; Beasley CM; Dananberg J
J Clin Endocrinol Metab; 2002 Jun; 87(6):2918-23. PubMed ID: 12050274
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.
Sowell M; Mukhopadhyay N; Cavazzoni P; Carlson C; Mudaliar S; Chinnapongse S; Ray A; Davis T; Breier A; Henry RR; Dananberg J
J Clin Endocrinol Metab; 2003 Dec; 88(12):5875-80. PubMed ID: 14671184
[TBL] [Abstract][Full Text] [Related]
3. The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients.
Chiu CC; Chen KP; Liu HC; Lu ML
J Clin Psychopharmacol; 2006 Oct; 26(5):504-7. PubMed ID: 16974193
[TBL] [Abstract][Full Text] [Related]
4. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
[TBL] [Abstract][Full Text] [Related]
7. Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.
Manu P; Correll CU; Wampers M; van Winkel R; Yu W; Shiffeldrim D; Kane JM; De Hert M
Schizophr Res; 2013 Feb; 143(2-3):358-62. PubMed ID: 23231880
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretion and sensitivity after single-dose amisulpride, olanzapine or placebo in young male subjects: double blind, cross-over glucose clamp study.
Kopf D; Gilles M; Paslakis G; Medlin F; Lederbogen F; Lehnert H; Deuschle M
Pharmacopsychiatry; 2012 Sep; 45(6):223-8. PubMed ID: 22426845
[TBL] [Abstract][Full Text] [Related]
9. Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks.
Hardy TA; Meyers AL; Yu J; Shankar SS; Steinberg HO; Porksen NK
Diabetes Care; 2007 Jan; 30(1):157-8. PubMed ID: 17192353
[No Abstract] [Full Text] [Related]
10. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
11. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M
Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441
[TBL] [Abstract][Full Text] [Related]
13. Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.
Briken P; Nika E; Moritz S; Haasen C; Perro C; Yagdiran O; Naber D; Krausz M
Schizophr Res; 2002 Oct; 57(2-3):311-3. PubMed ID: 12223264
[No Abstract] [Full Text] [Related]
14. A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.
Roerig JL; Mitchell JE; de Zwaan M; Crosby RD; Gosnell BA; Steffen KJ; Wonderlich SA
J Clin Psychopharmacol; 2005 Oct; 25(5):413-8. PubMed ID: 16160615
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Tarazi FI; Zhang K; Baldessarini RJ
J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration.
Chintoh AF; Mann SW; Lam L; Lam C; Cohn TA; Fletcher PJ; Nobrega JN; Giacca A; Remington G
J Clin Psychopharmacol; 2008 Oct; 28(5):494-9. PubMed ID: 18794643
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
18. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
Ratzoni G; Gothelf D; Brand-Gothelf A; Reidman J; Kikinzon L; Gal G; Phillip M; Apter A; Weizman R
J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):337-43. PubMed ID: 11886029
[TBL] [Abstract][Full Text] [Related]
19. Severe hyperglycemia induced by olanzapine was improved with a recovery of insulin secretion after switching to risperidone and introducing insulin therapy.
Nakamura M; Nagamine T
Intern Med; 2010; 49(23):2635-7. PubMed ID: 21139307
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
Smith RC; Rachakonda S; Dwivedi S; Davis JM
Psychiatry Res; 2012 Oct; 199(3):159-63. PubMed ID: 22475524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
